ClinicalTrials.gg
CompletedNCT02742311EPCSVUpdated Jan 13, 2022

EuroPainClinics® Study V (Prospective Observational Study)

An interventional study of Endoscopic disectomy in Back Pain and Intervertebral Disc Herniation, sponsored by Europainclinics z.ú.. Completed at 1 site in Slovakia. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-13.

Sponsored by Europainclinics z.ú. · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

In this prospective observational trial the effect of the Endoscopic discectomy microinvasive therapy should be examined in (approximately 500) adult patients with low back pain.

02

Conditions studied

  • Back Pain
  • Intervertebral Disc Herniation
03

In context

Back Pain

729 studies on the registry are indexed under Back Pain; 110 are open to participants now.

This study's enrollment of 500 is above the median of 70 across 594 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Europainclinics z.ú. is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • lumbar disc prolapse with unilateral radiculopathy, on clinical evaluation, positive straight leg raise or femoral stretch test, and identification of a single nerve root lesion on MRI

Exclusion criteria

Exclusion Criteria:

  • The exlusion criteria: bilateral root symptoms, double root involvement, cauda equina syndrome and negative MRI Picture for disc herniation, unsigned infomed consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
500 participants (actual)

Study arms

  • Active comparator
    transforaminal endoscopic discectomy

    Procedure: Endoscopic disectomy

  • Active comparator
    interlaminar endoscopic discectomy

    Procedure: Endoscopic disectomy

Interventions

  • ProcedureEndoscopic disectomy

    Endoscopic discectomy is an established method for treatment of lumbar disc herniation. Edoscopic discectomy provides a safe and minimal access corridor for lumbar discectomy. The technique also allows early postoperative mobilization and faster return to work.

06

What researchers measure

Primary outcomes

  1. 1.Pain as assessed by the Visual analogue scale All acquired information will be noted in to the special anonymous protocol

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 3 years

Secondary outcomes

  1. 2.Pain localization as assessed by note of radiating dermatome as neurologic examination

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 3 years

  2. 3.Pain progress as assessed by global pain scale

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 3 years

  3. 4. Changes in analgesics drugs consumption as assessed by equianalgesic dose ratios for opioids

    All acquired information will be noted in to the special anonymous protoco

    Time frame: 3 years

07

Study locations

1 site
  • Europainclinics algesiology ambulance
    Bardejov, Slovakia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2021 to primary completion in Dec 2021, 0 months.

Of 259 non-industry interventional studies with no phase under Back Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's 0 months is below that.

Counting every sponsor, half of 294 studies reached it within 13 months; a quarter within 5 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 10, 2016
First posted
Apr 19, 2016
StartActual
Dec 31, 2021
Primary completionActual
Dec 31, 2021
CompletionActual
Dec 31, 2021
Last update
Jan 13, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02742311
Lead sponsor
Europainclinics z.ú.
Responsible party
Sponsor
First posted
Apr 19, 2016
Start date
Dec 31, 2021
Primary completion
Dec 31, 2021
Completion
Dec 31, 2021
Last update
Jan 13, 2022

Study contacts

Miroslav Burianek, MD MPH
study chair · Director

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion